Home Infusion Therapy: World Market Size, Share & Trends Analysis Report, 2019 - ResearchAndMarkets.com

The "Home
Infusion Therapy Market Size, Share & Trends Analysis Report By
Application (Anti-Infective, Endocrinology), By Product (Infusion Pumps,
IV Cannulas, Intravenous Sets, Needleless Connectors), And Segment
Forecasts, 2019 - 2026" report has been added to ResearchAndMarkets.com's
offering.

The global home infusion therapy market size is expected to reach USD
38.7 billion by 2026 registering a CAGR of 7.2% from 2019 to 2026,
according to this new report.

Rapid technological advancements are some major factors contributing to
the market growth. Home infusion is gradually being considered as an
alternative to extended stay in hospitals or nursing homes for patients
suffering from chronic diseases. With the administration of medications
in home settings, patients recover faster, are more comfortable, and
save money. Several government and non-government programs aimed at
reducing the burden of hospital stays by establishing infusion centers
that provide quick IV infusion services are likely to have a positive
impact on the market.

Furthermore, favorable government policies and regulations are expected
to propel the industry growth. In addition, rising prevalence of
diseases, such as Cardiovascular Diseases (CVDs), cancer, diabetes, and
other life-threatening conditions, is expected to be a high impact
rendering driver for the market. According to the WHO, at present, all
the aforementioned diseases account for 60% of total deaths and 43% of
the disease burden in U.S. This creates the need to infuse nutritional
products that contain glutamine, phospholipids, glucose, and amino
acids, which in turn, is expected to boost the market growth in the
region.

Further key findings from the study suggest:

• Infusion pumps led the product segment in 2018 owing to their
  extensive use for the delivery of fluids, such as medications and
  nutrients, during infusion therapy
• Needleless connectors is the fastest-growing product segment over the
  forecast period. These devices provide protection from needlestick
  injuries
• Anti-infective segment held the largest share in 2018 owing to a large
  number of procedures performed for administering antibiotics and
  antifungals
• The chemotherapy segment is expected to witness lucrative growth
  during the forecast period on account of initiatives undertaken
  pertaining to cancer treatment, such as development of infusion
  centers by the Cancer Treatment Centers of America
• The market is highly competitive and is marked by the presence of key
  companies
• Most of these companies focus on new product development to maintain
  their position in the global home infusion therapy market

Companies Mentioned

• B. Braun Melsungen AG
• Baxter
• Caesarea Medical Electronics
• CareFusion Corporation
• Fresenius Kabi
• ICU Medical Inc.
• JMS Co. Ltd.
• Smiths Medical
• Terumo Corporation

For more information about this report visit https://www.researchandmarkets.com/r/1xolj2

View source version on businesswire.com: https://www.businesswire.com/news/home/20190606005596/en/